Country planning for health interventions under development: Lessons from the malaria vaccine decision-making framework and implications for other new interventions

Health Policy and Planning

Volumn 27, Issue SUPPL.2, 2012, Pages

  Brooks, Alan ^a,b   Ba Nguz, Antoinette ^c  

^a PATH Malaria Vaccine Initiative   (France)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c ACS   (Kenya)

Author keywords

decision making; developing countries; Health policy; interventions; organizational; policy making; technologies; vaccines

Indexed keywords

MALARIA VACCINE;

ARTICLE; DEVELOPING COUNTRY; HEALTH CARE PLANNING; HUMAN; MANAGEMENT; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE;

DECISION MAKING, ORGANIZATIONAL; DEVELOPING COUNTRIES; HEALTH PLANNING; HUMANS; IMMUNIZATION PROGRAMS; MALARIA VACCINES; POLICY MAKING;

EID: 84860146890     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czs039     Document Type: Article

References (41)

1. Agnandji ST, Lell B, Soulanoudjingar SS et al. 2011. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. New England Journal of Medicine 365: 1863-75.
2. Amin AA, Zurovac D, Kangwana BB et al. 2007. The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Malaria Journal 6: 72.
3. Bosman A, Mendis K. 2007. A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. American Journal of Tropical Medicine & Hygiene 77(6 Suppl):193-7.
4. Bryson M, Duclos P, Jolly A, Bryson J. 2010. A systematic review of national immunization policy making processes. Vaccine 28: A6-12.
5. DeRoeck D. 2004. The importance of engaging policy-makers at the outset to guide research on and introduction of vaccines: the use of policy-maker surveys. Journal of Health, Population & Nutrition 22: 322-30.
6. DeRoeck D, Clemens JD, Nyamete A et al. 2005. Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia. Vaccine 23: 2762-74.
7. Frost LJ, Reich MR. 2009. Creating access to health technologies in poor countries. Health Affairs 28: 962-73.
8. GAVI Alliance. 2008. GAVI Alliance Handbook: Country Proposal and Monitoring Processes. Geneva: GAVI Alliance.
9. GAVI Alliance. 2004. Report of the Hib Task Force, 14th GAVI Board Meeting. Geneva: GAVI Alliance.
10. Gericke CA, Kurowski C, Ranson MK, Mills A. 2005. Intervention complexity-a conceptual framework to inform priority-setting in health. Bulletin of the World Health Organization 83: 285-93.
11. Gessner BD, Duclos P, DeRoeck D, Nelson EA. 2010. Informing decision makers: experience and process of 15 National Immunization Technical Advisory Groups. Vaccine 28(Suppl. 1):A1-5.
12. GFATM. 2010. Guidelines and Requirements for Country Coordinating Mechanisms. Geneva: Global Fund to Fight AIDS, Tuberculosis & Malaria.
13. Grindle MS, Thomas JW. 1991. Public Choices and Policy Change: The Political Economy of Reform in Developing Countries. Baltimore: The Johns Hopkins University Press.
14. Grundy J. 2010. Country-level governance of global health initiatives: an evaluation of immunization coordination mechanisms in five countries of Asia. Health Policy and Planning 25: 186-96.
15. Hajjeh RA, Privor-Dumm L, Edmond K et al. 2010. Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience. Vaccine 43: 7123-9.
16. Hutubessy R, Chisholm D, Edejer TT. 2003. Generalized costeffectiveness analysis for national-level priority-setting in the health sector. Cost-Effectiveness & Resource Allocation 1: 8.
17. Kane MA, Brooks A. 2002. New immunization initiatives and progress toward the global control of hepatitis B. Current Opinion in Infectious Diseases 15: 465-9.
18. Katahoire RA, Jitta J, Kivumbi G et al. 2008. An assessment of the readiness for introduction of the HPV vaccine in Uganda. African Journal of Reproductive Health 12: 159-72.
19. Kim SY, Sweet S, Slichter D, Goldie SJ. 2010. Health and economic impact of rotavirus vaccination in GAVI-eligible countries. BMC Public Health 10: 253.
20. Kingdon JW. 1995. Agendas, Alternatives and Public Policies. 2nd edn. New York: Longman.
21. LaForce FM, Konde K, Viviani S et al. 2007. The meningitis vaccine project. Vaccine 3(Suppl. 1):A97-100.
22. Levine OS, Hajjeh RA, Wecker T et al. 2010a. A policy framework for accelerating adoption of new vaccines. Human Vaccines 6: 1021-4.
23. Levine OS, Knoll MD, Jones A et al. 2010b. Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions. Current Opinion in Infectious Diseases 23: 236-41.
24. Malaria vaccine decision-making framework. 2011. Online at: http:// www.malvacdecision.net, accessed 26 May 2011.
25. Malaria Vaccine Funders Group. 2006. Malaria Vaccine Technology Roadmap. Online at: http://www.malariavaccine.org/files/Malaria-Vaccine-TRM-Final-000. pdf, accessed 19 November 2010.
26. Mitchell V, Walker D, Zuber P, Lydon P, Ahun M. 2005. Evidencedbased decision making about Hib vaccination. The Lancet 365: 936-7.
27. Mulligan JA, Mandike R, Palmer N et al. 2006. The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania. Tropical Medicine & International Health 11: 452-61.
28. Policy Cures. 2010. The G-FINDER Report: Neglected Disease Research and Development: Is the global financial crisis changing R&D? Sydney: Policy Cures.
29. Princeton Survey Research Associates International. 2008. Survey Evaluation of the Malaria Vaccine Decision Making Framework Process. Online at: http://www.malvacdecision.net/evaluation.html, accessed 19 November 2010.
30. Shearer JC, Stack ML, Richmond MR et al. 2010. Accelerating policy decisions to adopt Haemophilus influenzae type B vaccine: a global, multivariable analysis. PLoS Medicine 7: e1000249.
31. Shretta R, Omumbo J, Rapuoda B, Snow RW. 2000. Using evidence to change antimalarial drug policy in Kenya. Tropical Medicine & International Health 5: 755-64.
32. Stop TB Partnership, WHO. 2007. New Technologies for Tuberculosis Control: A Framework for their Adoption, Introduction and Implementation. Report No. WHO/HTM/STB/2007.40. Geneva: World Health Organization.
33. Vekemans J, Leach A, Cohen J. 2009. Development of the RTS,S/AS malaria candidate vaccine. Vaccine 27(Suppl. 6):G67-71.
34. Victora CG. 2010. LiST: using epidemiology to guide child survival policymaking and programming. International Journal of Epidemiology 39: 650-2.
35. Walt G. 1994. Health Policy: An Introduction to Process and Power. London: Zed Books Ltd.
36. WHO. 2002. Operational Guide for National Tuberculosis Control Programmes on the Introduction and Use of Fixed Dose Combination Drugs. Report No. WHO/CDS/TB/2002.308 and WHO/EDM/PAR/2002. 6. Geneva: World Health Organization.
37. WHO. 2004. Review panel on Haemophilus influenzae type b (Hib) disease burden in Bangladesh, Indonesia and other Asian countries. Weekly Epidemiological Record 79: 173-5.
38. WHO. 2005. Vaccine Introduction Guidelines: Adding a Vaccine to a National Immunization Programme: Decision and Implementation. Report No. WHO/IVB/05.18. Geneva: World Health Organization.
39. WHO. 2010. World Malaria Report: 2010. Geneva: World Health Organization.
40. WHO, UNAIDS, UNICEF. 2010. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Geneva: World Health Organization.
41. Williams HA, Durrheim D, Shretta R. 2004. The process of changing national malaria treatment policy: lessons from country-level studies. Health Policy and Planning 19: 356-70.